Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma

Completed

Conditions studied: Glaucoma

In brief

To determine the area under the Receiver Operator Characteristic Curve (AUC) for the Ganglion Cell Analysis (GCA) average thickness.

Key facts

Study ID

NCT01272102

Run by

Carl Zeiss Meditec, Inc.

People needed

119

Starts

2010-11-01

Expected to finish

2011-03-01

Last updated by the study team

2013-06-25

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age of 40 years or older
• Diagnosed to have glaucoma by the Principal Investigator or co-investigator
• Able and willing to make the required study visits
• Able and willing to give consent and follow study instructions

You may not qualify if…

• Ophthalmic:
• Best corrected visual acuity in either eye worse than 20/40 on a Snellen chart or on a Snellen equivalent acuity chart.
• Refractive error outside -12.00D to +8.00D spherical range or >-3.00D cylinder.
• Previous vitreoretinal surgery in study eye.
• Vitreoretinal traction or epiretinal membrane in the study eye.
• Any active infection of anterior or posterior segments.
• Evidence of diabetic retinopathy, diabetic macular edema, or other vitreoretinal disease in the study eye upon dilated examination, or upon evaluation of retinal photos.
• Systemic:
• History of diabetes, leukemia, AIDS, uncontrolled systemic hypertension, dementia or multiple sclerosis.
• A life threatening or debilitating disease.
• Participation in any study involving a non-FDA approved investigational drug (IND) within the past month, or ongoing participation in a study with a non-FDA approved or cleared investigational device (IDE).
• Current or recent (within the past 14 days) use of an agent with photosensitizing properties by any route (e.g., Visudyne®, ciprofloxacin, Bactrim®, doxycycline, etc.).
• Concomitant use of hydrochloroquine and/or chloroquine.

Where it is running

• Stanford Eye Institute — Palo Alto, California, United States
• Bascom Palmer Eye Institute — Miami, Florida, United States
• Glaucoma Associates of Texas — Dallas, Texas, United States
• Utah Eye Institute — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.